awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36385285-860E4379-3D5F-4711-B12E-93584EE4BB3B
Q36385285-860E4379-3D5F-4711-B12E-93584EE4BB3B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36385285-860E4379-3D5F-4711-B12E-93584EE4BB3B
Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patients.
P2860
Q36385285-860E4379-3D5F-4711-B12E-93584EE4BB3B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36385285-860E4379-3D5F-4711-B12E-93584EE4BB3B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
808fbf45c473b47723c8a18d49c08905a7afcd3b
P2860
Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study.